JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roszkowski, A. P.
Right arrow Articles by Yelnosky, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roszkowski, A. P.
Right arrow Articles by Yelnosky, J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 156, Issue 2, 238-245, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


STRUCTURE-ACTIVITY RELATIONSHIPS AMONG A SERIES OF ACETYLENIC CARBAMATES RELATED TO McN-A-343

Adolph P. Roszkowski 1 and John Yelnosky 1

1 Department of Pharmacology, Research Division, McNeil Laboratorie, Incorporated, Fort Washington, Pennsylvania

A study was undertaken of the relation between autonomic effects and chemical structure among a cries of compounds related to McN-A-343, 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride. A shift of the chlorine atom from position 3 to position 4 produces a 3-fold enhancement of ganglionic stimulant activity qualitatively similar to that induced by McN-A-343, i.e., it is readily antagonized by atropine. Shift of the chlorine atom to position 2 causes a decrease to [unknown] the activity of McN-A-343. m-Trifluoro or 2.5-dichloro substitution also reduces activity, as does saturation of the acetylenic group to an ethylenic group. The fully saturated material is devoid of ganglionic stimulant effects, producing instead depolarizing-type neuromuscular blockade; this substance is approximately [unknown] to [unknown] as active as decamethonium. Only the quaternary ammonium compounds display autonomic effects of consequence. The triethylammonium substituted analog displays a mixture of short-acting ganglionic blockade (hexamethoniumlike) and atropine-like effects. Removal of the chlorophenyl portion of this molecule results in the formation of compounds which display marked cholinomimetic activity. These range in potency from [unknown] to frac12 times that of acetylcholine.

Submitted on March 3, 1966
Accepted on December 9, 1966




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Valant, K. J. Gregory, N. E. Hall, P. J. Scammells, M. J. Lew, P. M. Sexton, and A. Christopoulos
A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity: MUSCARINIC PARTIAL AGONIST McN-A-343 AS A BITOPIC ORTHOSTERIC/ALLOSTERIC LIGAND
J. Biol. Chem., October 24, 2008; 283(43): 29312 - 29321.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.